Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Nov;87(22):9067-71.
doi: 10.1073/pnas.87.22.9067.

Immunological studies of the basis for the apathogenicity of simian immunodeficiency virus from African green monkeys

Affiliations

Immunological studies of the basis for the apathogenicity of simian immunodeficiency virus from African green monkeys

S G Norley et al. Proc Natl Acad Sci U S A. 1990 Nov.

Abstract

Potential reasons for the lack of pathogenicity of the simian immunodeficiency virus SIVagm in its natural host, the African green monkey (AGM, Cercopithecus aethiops), were investigated with respect to immunological mechanisms. The functional immune response of monkeys to infection was similar (though not identical) to that of humans to infection with human immunodeficiency virus type 1 (HIV-1). In the sera of infected animals, neutralizing antibodies were found to be low or absent, and in particular there was no neutralization of the various isolates by homologous sera. There was no detectable antibody/complement cytotoxicity, though AGM sera were able to initiate antibody-dependent cellular cytolysis of infected cells in the presence of healthy effector peripheral blood lymphocytes. As in the human/HIV system, macrophages from AGMs are readily infected by SIVagm. Two possibly important differences between the AGM/SIVagm system and the human/HIV system are (i) the low immune response of the AGMs to the core protein of SIVagm and (ii) the significantly lower inhibitory effect of SIVagm proteins on the proliferation of AGM lymphocytes.

PubMed Disclaimer

References

    1. J Virol. 1988 Nov;62(11):4123-8 - PubMed
    1. Science. 1988 Jul 15;241(4863):357-9 - PubMed
    1. J Acquir Immune Defic Syndr. 1988;1(3):284-94 - PubMed
    1. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2892-6 - PubMed
    1. J Virol. 1989 Aug;63(8):3257-60 - PubMed

Publication types

MeSH terms